Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$530M |
| 2 |
AbbVie
ABBV
|
+$429M |
| 3 |
Boston Scientific
BSX
|
+$292M |
| 4 |
Snap
SNAP
|
+$241M |
| 5 |
Royalty Pharma
RPRX
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$327M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$295M |
| 3 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$294M |
| 4 |
Sysco
SYY
|
+$209M |
| 5 |
Shopify
SHOP
|
+$176M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.65% |
| 2 | Healthcare | 19.7% |
| 3 | Consumer Discretionary | 10.81% |
| 4 | Financials | 9.9% |
| 5 | Communication Services | 8.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Mid-America Apartment Communities
MAA
$15.8B
| $70.8M | 0.04% |
617,075
-399,284
| -39% | -$45M |
|
402
Zebra Technologies
ZBRA
$13.5B
| $70.7M | 0.04% |
276,125
+37,086
| +16% | +$8.69M |
|
|
ODT
403
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $70.2M | 0.04% |
1,657,079
+75,151
| +5% | +$2.43M |
|
404
Otis Worldwide
OTIS
$28B
| $70M | 0.04% |
+1,230,418
| New | +$63.8M |
|
405
Kroger
KR
$36.3B
| $69.7M | 0.04% |
2,060,002
+1,697,549
| +468% | +$55.1M |
|
406
Wells Fargo
WFC
$263B
| $69.5M | 0.04% |
2,716,334
-1,087,119
| -29% | -$29.7M |
|
407
Descartes Systems
DSGX
$6.48B
| $69.3M | 0.04% |
1,317,512
-4,120
| -0.3% | -$183K |
|
408
CAE Inc. Common Shares
CAE
$8.48B
| $69.3M | 0.04% |
4,286,333
-112,610
| -3% | -$1.74M |
|
409
Omnicom Group
OMC
$24.6B
| $69.1M | 0.04% |
1,264,866
-1,041,363
| -45% | -$56.7M |
|
410
Sonoco
SON
$5.99B
| $69M | 0.04% |
1,318,879
+693,546
| +111% | +$34.3M |
|
411
American Water Works
AWK
$27B
| $68.7M | 0.04% |
533,716
-30,000
| -5% | -$3.74M |
|
|
AKRO
412
DELISTED
Akero Therapeutics
AKRO
| $68.2M | 0.04% |
2,738,518
-28,302
| -1% | -$647K |
|
|
IGMS
413
DELISTED
IGM Biosciences
IGMS
| $67.7M | 0.04% |
927,350
-551,455
| -37% | -$33.5M |
|
414
Alexandria Real Estate Equities
ARE
$9.41B
| $67.6M | 0.04% |
416,671
-4,447
| -1% | -$680K |
|
415
eBay
EBAY
$52.1B
| $67.2M | 0.04% |
1,280,619
+432,776
| +51% | +$18.3M |
|
|
VMW
416
DELISTED
VMware, Inc
VMW
| $67.1M | 0.04% |
433,123
-63,224
| -13% | -$8.69M |
|
417
Simply Good Foods
SMPL
$941M
| $67M | 0.04% |
3,606,495
-64,626
| -2% | -$1.14M |
|
418
Archer Daniels Midland
ADM
$40.1B
| $66.9M | 0.04% |
1,676,450
-138,955
| -8% | -$5.2M |
|
|
ZGNX
419
DELISTED
Zogenix, Inc.
ZGNX
| $66.9M | 0.04% |
2,475,492
+3,347
| +0.1% | +$92.3K |
|
420
argenx
ARGX
$54.6B
| $66.8M | 0.04% |
296,647
-2,242
| -0.8% | -$398K |
|
421
Maximus
MMS
$3.31B
| $66.6M | 0.04% |
945,491
+1,089
| +0.1% | +$73.2K |
|
422
Glaukos
GKOS
$8.89B
| $66.4M | 0.04% |
1,727,489
-666,431
| -28% | -$24.8M |
|
423
W.W. Grainger
GWW
$66B
| $66.2M | 0.04% |
210,871
+112,121
| +114% | +$32.4M |
|
424
Ametek
AME
$55.3B
| $66M | 0.04% |
738,171
-146,243
| -17% | -$12.3M |
|
425
Atlantic Union Bankshares
AUB
$6.11B
| $65.4M | 0.04% |
2,822,711
+181,757
| +7% | +$4.09M |
|
Similar funds
Janus Henderson Group's Q2 2020 Portfolio in Review
As of Q2 2020, Janus Henderson Group held 1,423 positions worth $178B, up 23% from $145B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Janus Henderson Group's Q2 2020 filing shows 132 new, 511 increased, 643 reduced and 125 closed positions. Its largest new stake was Royalty Pharma: 4,507,138 shares worth $219M. The largest sale was Boeing, an estimated $327M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q2 2020 buy was Royalty Pharma: 4,507,138 shares worth $219M.
- Janus Henderson Group added most to T-Mobile US in Q2 2020, an estimated $530M increase.
- Janus Henderson Group's biggest Q2 2020 reduction was Boeing, cutting an estimated $327M.
- Janus Henderson Group fully exited Allergan plc in Q2 2020, selling an estimated $128M.
- Janus Henderson Group's ten largest holdings make up 23% of its $178B portfolio in Q2 2020.
- Janus Henderson Group opened 132 new positions and closed 125 in Q2 2020.
- Janus Henderson Group's portfolio value rose 23% quarter-over-quarter to $178B.
Based on Janus Henderson Group's 13F filing for Q2 2020, filed 14 Aug 2020.